Human pathogenic microbes : diseases and concerns / Manzoor Ahmad Mir.

Format:

Book

Author/Creator:

Mir, Manzoor Ahmad, author.

Series:

Developments in microbiology

Language:

English

Subjects (All):

Medical microbiology.

Communicable diseases.

Drug resistance in microorganisms.

Communicable Diseases.

Medical Subjects:

Communicable Diseases.

Genre:

Electronic books.

Physical Description:

1 online resource (1 volume).

Place of Publication:

London, United Kingdom : Academic Press, 2022.

System Details:

text file

Contents:

Front Cover

HUMAN PATHOGENIC MICROBES

HUMAN PATHOGENIC MICROBES: DISEASES AND CONCERNS

Copyright

Contents

List of contributors

Preface

Acknowledgments

Abbreviation list

Glossary

1

Human pathogenic microbes (bacterial and fungal) and associated diseases

1.1 Introduction

1.1.1 Modes of transmission

1.2 Human-pathogen interaction

1.3 Human pathogenic fungal microorganisms

1.3.1 Candida species

1.3.2 Aspergillus species

1.3.3 Cryptococcus species

1.4 Human pathogenic fungal diseases

1.4.1 Candidiasis

1.4.2 Aspergillosis

1.4.3 Cryptococcosis

1.5 Human pathogenic bacterial microorganisms

1.5.1 Mycobacterium tuberculosis

1.5.2 Vibrio cholera

1.5.3 Staphylococcus aureus

1.6 Human pathogenic bacterial diseases

1.6.1 Tuberculosis (TB)

1.6.2 Cholera

1.6.3 Streptococcus pneumoniae and other associated infections

1.7 Summary and future perspectives

References

2

Evolution of antimicrobial drug resistance in human pathogenic bacteria

2.1 Introduction

2.2 Current status of resistance to antibacterial drugs

2.3 Surveillance of antibacterial resistance/tolerance

2.4 Molecular mechanisms of antimicrobial drug resistance in human pathogenic bacteria

2.5 Resistance to antibacterial drugs in selected bacteria of international concern

2.5.1 Escherichia coli-resistance to third-generation cephalosporins and fluoroquinolones

2.5.2 Klebsiella pneumoniae-resistance to third-generation cephalosporins and to carbapenems

2.5.3 Staphylococcus aureus-resistance to methicillin

2.5.4 Streptococcus pneumoniae-resistance (nonsusceptibility) to penicillin

2.5.5 Nontyphoidal salmonella-resistance to fluoroquinolones

2.5.6 Shigella species-resistance to fluoroquinolones

2.5.7 Neisseria gonorrhoeae-decreased susceptibility to third-generation cephalosporins

2.6 Economic burden of antibacterial resistance and its impacts on human health

2.6.1 Health burden

2.6.2 Economic burden

2.7 Surveillance of antimicrobial drug resistance in disease-specific programs

2.7.1 Surveillance of drug-resistant tuberculosis

2.7.2 Surveillance of antimalarial therapeutic efficacy and resistance

2.7.3 Surveillance of anti-HIV drug resistance

2.7.4 Surveillance of anti-influenza drug resistance

2.8 Evolution of drug resistance in mycobacterium tuberclosis

2.8.1 Global public health response to drug-resistant tuberclosis

2.9 Future perspectives

3

Evolution of antimicrobial drug resistance in human pathogenic fungi

3.1 Introduction

3.2 Molecular mechanisms governing antimicrobial drug resistance phenomenon in the human pathogenic fungi

3.2.1 Transport alteration: drug efflux via overexpression/activation of membrane transporters

3.2.2 Target alteration: altered ergosterol biosynthesis

3.2.3 Genomic alterations/genomic plasticity

Notes:

Print version record.

Other Format:

Print version: HUMAN PATHOGENIC MICROBES.

OCLC:

1305063150

Access Restriction:

Restricted for use by site license.